TABLE 3

Lymphocyte Toxicity After PRRT

Patient blood identifierBaseline PBL count before first treatment (cells × 103/mm3)PBL counts before indicated treatment* (cells × 103/mm3)PBL count 2 wk after indicated treatment* (cells × 103/mm3)PBL reduction (%) before indicated treatment to 2 wk after indicated treatmentPBL reduction (%) between baseline and 2 wk after indicated treatment
P1.11.61.60.66363
P1.21.60.80.53869
P1.31.61.00.55069
P2.21.41.00.55064
P2.31.40.50.42071
P2.51.40.50.34079
P3.32.91.80.95069
P3.42.91.10.91869
P4.11.21.20.83333
P5.11.51.50.84747
P6.12.32.30.96161
P7.32.50.50.34088
P8.31.70.90.63365
P9.31.30.90.45670
P10.51.91.20.65068
P11.62.31.71.51234
  • * “Indicated treatment” refers to treatment cycle number denoted by last digit in patient blood identifier.

  • Patients are numbered from P1 to P11 followed by treatment cycle number.